|
Orenes-Piñero E, Hernández-Romero D, Romero-Aniorte AI, Martínez M, García-Honrubia A, Caballero L, Garrigos-Gómez N, Andreu-Cayuelas JM, González J, Feliu E, Climent V, Nicolás-Ruiz F, De La Morena G, Valdés M, Lip GY, Marín F. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. QJM. 2014 Aug;107(8):613-21. doi: 10.1093/qjmed/hcu046. PubMed PMID: 24599807.
AÑO: 2014; IF: 2.495
|
24599807
|
Roldán V, Arroyo AB, Salloum-Asfar S, Manzano-Fernández S, García-Barberá N, Marín F, Vicente V, González-Conejero R, Martínez C. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation. Thromb Haemost. 2014 Oct;112(4):781-8. doi: 10.1160/TH14-01-0092. PubMed PMID: 25008481.
AÑO: 2014; IF: 4.984
|
|
Hernández-Romero D, Jover E, Martínez CM, Andreu-Cayuelas JM, Orenes-Piñero E, Romero-Aniorte AI, Casas T, Cánovas S, Montero-Argudo JA, Valdés M, de la Morena G, Marín F. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy. Eur J Clin Invest. 2015 Feb;45(2):179-86. doi: 10.1111/eci.12394. PubMed PMID: 25524713.
AÑO: 2015; IF: 2.687
|
|
Orenes-Piñero E, Pineda J, Roldán V, Hernández-Romero D, Marco P, Tello-Montoliu A, Sogorb F, Valdés M, Lip GY, Marín F. Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State. J Atheroscler Thromb. 2015;22(6):610-7. doi: 10.5551/jat.26161. PubMed PMID: 25737193.
AÑO: 2015; IF: 2.411
|
|
Lahoz-Tornos Á, Vilchez-Aguilera JA, Hernandez-Romero D, Romero-Aniorte AI, Orenes-Piñero E, Jara-Rubio R, Del Saz-Ortiz A, Arribas-Leal JM, García-Alberola A, Valdés-Chávarri M, Marín-Ortuño F. [HDL cholesterol and high-sensitive troponin T as predictive biomarkers of atrial fibrillation after heart surgery]. Arch Cardiol Mex. 2015 Apr-Jun;85(2):111-7. doi: 10.1016/j.acmx.2014.12.007. Spanish. PubMed PMID: 25716679.
AÑO: 2015
|